@brendalee I did a Google search and it does not appear it has been approved (yet) in Canada. The US Food and Drug Administration (FDA) approved relacorilant in combination with nab-paclitaxel for treating platinum-resistant ovarian cancer on March 25, 2026. I could not find any approval information for Canada. The caveat is that I'm not a medical expert or researcher and I'm relying on "Dr. Google" for this information. I would suggest however that historical patterns tend to show the U.S. approving things prior to Canada (not always but my sense is more often than not). The good thing is it was approved by them and hopefully that means, it's now being assessed by Health Canada. 🤞
@LeslieA perhaps that's a question for the upcoming conference. What OVC treatments approved by other countries, particularly the U.S., are currently being assessed by Health Canada?
#Clinicaltrialsandresearch #Treatmentandsideeffects
-------------------------------------------